Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Diantha Duvall currently holds 48,285 shares of GENOCEA BIOSCIENCES, INC. (GNCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Diantha Duvall has been a net seller of GNCA stock. They have purchased $0 and sold $59.5K worth of shares.
Diantha Duvall's most recent insider trade was on Jul 7, 2026, when they sold 48,285 shares at $5.29 per share.
Diantha Duvall serves as Executive at GENOCEA BIOSCIENCES, INC. (GNCA). They have executed 22 insider transactions totaling $59.5K over their tenure at the company.
Diantha Duvall holds the position of Executive at GENOCEA BIOSCIENCES, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Diantha Duvall has shown a selling trading pattern, with $0 in total purchases and $59.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Diantha Duvall was on May 21, 2024, when they purchased $453.2K worth of CRIS shares. This transaction involved 39,000 shares at $11.62 per share.
Diantha Duvall currently owns 48,285 shares of GENOCEA BIOSCIENCES, INC. (GNCA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Diantha Duvall's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Diantha Duvall has 22 Form 4 filings on record as an insider at GENOCEA BIOSCIENCES, INC..
Set alerts for Diantha Duvall and 40,000+ other insiders.